Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
International Journal of Molecular Sciences|June 10, 2023
Evaluation of the Novel Sepsis Biomarker Host-Derived Delta-like Canonical Notch Ligand 1-A Secondary Analysis of 405 Patients Suffering from Inflammatory or Infectious DiseasesTobias Hölle, Patrick Rehn, Konstantinos Leventogiannis, et al.Critical Care (London, England)|February 6, 2024
qSOFA combined with suPAR for early risk detection and guidance of antibiotic treatment in the emergency department: a randomized controlled trialMaria Evangelia Adami, Antigone Kotsaki, Nikolaos Antonakos, et al.The Journal of Antimicrobial Chemotherapy|October 16, 2024
Population pharmacokinetics/pharmacodynamics of minocycline plus rifampicin in patients with complicated skin and skin structure infections caused by MRSASonia Luque Pardos, William Hope, Antigone Kotsaki, et al.Cell|September 17, 2020
Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the ElderlyEvangelos J Giamarellos-Bourboulis, Maria Tsilika, Simone Moorlag, et al.Critical Care Medicine|October 17, 2024
Modulation of Metabolomic Profile in Sepsis According to the State of Immune ActivationEleftheria Kranidioti, Isis Ricaño-Ponce, Nikolaos Antonakos, et al.Ebiomedicine|April 4, 2026
Molecular pathways driving clarithromycin benefit in community-acquired pneumonia: analysis of the ACCESS randomised trialEmmanouil Stylianakis, Nikolaos Kakavoulis, Spyros Foutadakis, et al.BMJ Open|January 5, 2023
ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocolAntigone Kotsaki, Peter Pickkers, Michael Bauer, et al.Cell Reports. Medicine|November 17, 2022
Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trialKonstantinos Leventogiannis, Evdoxia Kyriazopoulou, Nikolaos Antonakos, et al.Shock (Augusta, Ga.)|September 25, 2025
Blood Biomarker and Raman Analysis of Leukocytes in the Multicenter Intelligence Trials: At the Intensive Care Unit (Intelligence-1) and the Emergency Department (Intelligence-2)Evangelos J Giamarellos-Bourboulis, Daniel Thomas-Rüddel, Aikaterini Pistiki, et al.Cell Host & Microbe|April 23, 2020
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory FailureEvangelos J Giamarellos-Bourboulis, Mihai G Netea, Nikoletta Rovina, et al.Pageof 5